Baicalin down-regulating hepatitis B virus transcription depends on the liver-specific HNF4α-HNF1α axis.

Chengjie Xia,Wenyi Tang,Ping Geng,Haiyan Zhu,Wei Zhou,Hai Huang,Pei Zhou,Xunlong Shi
DOI: https://doi.org/10.1016/j.taap.2020.115131
IF: 4.46
2020-01-01
Toxicology and Applied Pharmacology
Abstract:Baicalin (BA) inhibits hepatitis B virus (HBV) RNAs production and reduces levels of the related hepatocyte nuclear factors (HNFs), although the underlying mechanism is unclear. In this study, we investigated the specific pathway by which BA regulates HBV transcription through the HBV-related HNFs. Following transfection of HepG2 cells with pHBV1.2, we observed that BA inhibited the production of HBV RNAs and viral proteins in a time-and dose-dependent manner. These effects were consistent with the downregulation of HNF1 alpha, which was abolished by HNF1 alpha-shRNA. The shRNA of HNF4 alpha, the upstream gene of HNF1 alpha, also remarkedly reduced HNF1 alpha expression and impaired the anti-HBV efficacy of BA, indicating that this function of BA depended on HNF4 alpha/HNF1 alpha axis. Furthermore, chromatin immunoprecipitation assay showed that BA significantly reduced HNF4 alpha-HNF1 alpha transactivation activity. The similar effects of BA were observed in entecavir (ETV)-resistant HBVrtM204V/rtLl80M transfected HepG2 cells. Thus, we proposed a mechanism for the anti-HBV activity of BA in an HNF4 alpha-HNF1 alpha-dependent manner, which impaired HNF4 alpha and HNF1 alpha transactivation, and effectively inhibited HBV transcription and viral replication.
What problem does this paper attempt to address?